𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The role of continuous subcutaneous insulin infusion therapy in patients with diabetic gastroparesis

✍ Scribed by D. Sharma; G. Morrison; F. Joseph; T. S. Purewal; P. J. Weston

Publisher
Springer
Year
2011
Tongue
English
Weight
78 KB
Volume
54
Category
Article
ISSN
0012-186X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The metabolic and hormonal effects of co
The metabolic and hormonal effects of continuous subcutaneous insulin infusion therapy in diabetic children
✍ G. SoltΓ©sz; D. MolnΓ‘r; T. Decsi; A. Hamar; L. Klujber πŸ“‚ Article πŸ“… 1988 πŸ› Springer 🌐 English βš– 577 KB

To find out whether the concurrent metabolic and hormonal abnormalities are corrected when normoglycaemia is achieved, two groups of diabetic children (newly-diagnosed and chronically-treated) were treated with insulin pumps. Fasting levels of metabolites, lipids and hormones were measured before an

Low subcutaneous degradation and slow ab
Low subcutaneous degradation and slow absorption of insulin in insulin-dependent diabetic patients during continuous subcutaneous insulin infusion at basal rate
✍ D. J. Chisholm; E. W. Kraegen; M. J. Hewett; S. Furler πŸ“‚ Article πŸ“… 1984 πŸ› Springer 🌐 English βš– 412 KB

As information on the absorption kinetics and local degradation of infused insulin is relevant to programming strategies for continuous subcutaneous insulin infusion, we examined the time relationship of systemic insulin appearance and quantitated subcutaneous degradation during a near-basal rate of

Induction of long-term normoglycemia wit
Induction of long-term normoglycemia without medication in Korean type 2 diabetes patients after continuous subcutaneous insulin infusion therapy
✍ Sunmin Park; Soo Bong Choi πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 120 KB πŸ‘ 1 views

## Abstract ## Background Our previous studies showed that some Korean type 2 diabetic patients could maintain long‐term normal blood glucose control without any medication, referred to as remission after a certain period of normalization of blood glucose level by continuous subcutaneous insulin i